Stock GMABGENMAB A/S
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Genmab A/S

Equities

GMAB

DK0010272202

Biotechnology & Medical Research

Real-time Estimate Cboe Europe
Other stock markets
 08:23:27 10/07/2025 pm IST 		5-day change 1st Jan Change
1,394.00 DKK +1.64% Intraday chart for Genmab A/S +7.70% -6.77%
01/07 Genmab Announces Changes to Its Executive Committee CI
01/07 Genmab's Chief Legal Officer Steps Down; Successor Named MT

Chart calendar Genmab A/S

faa070c6d1848e41d5ed2d4a1c9a4.HEamWJsxZCgtjwbniIHlZwCl6627A3Nwv8AsEWqeFL8.RiroG91bEVBpy1-4xtKhC0jPqpqDbwtJjYpnU1LweNcpPOIs1n8dQXrGbQ~57ce80de300723d1e84a8c6dfb102ee6

Upcoming events on Genmab A/S

07/08/2025 08:30 pm Q2 2025 Earnings Release
06/11/2025 09:30 pm Q3 2025 Earnings Release
25/02/2026 Q4 2025 Earnings Release (Projected)
13/05/2026 Q1 2026 Earnings Release (Projected)
12/08/2026 Q2 2026 Earnings Release (Projected)
11/11/2026 Q3 2026 Earnings Release (Projected)

Past events on Genmab A/S

17/06/2025 International Malignant Lymphoma Conference
15/06/2025 02:30 pm European Hematology Association Congress - Abstract Number: S247
15/06/2025 02:30 pm European Hematology Association Congress - Abstract Number: S245
15/06/2025 02:30 pm European Hematology Association Congress - Abstract Number S245
14/06/2025 10:00 pm European Hematology Association Congress - Abstract Number: PS1912
14/06/2025 10:00 pm European Hematology Association Congress - Abstract Number: PS1886
14/06/2025 10:00 pm European Hematology Association Congress - Abstract Number: PS1898
14/06/2025 10:00 pm European Hematology Association Congress - Abstract Number: PS1944
14/06/2025 10:00 pm European Hematology Association Congress - Abstract Number: PS1942
14/06/2025 10:00 pm European Hematology Association Congress - Abstract Number: PS1932
14/06/2025 10:00 pm European Hematology Association Congress - Abstract Number: PS1968
14/06/2025 10:00 pm European Hematology Association Congress - Abstract Number: PS1892
14/06/2025 07:00 pm European Hematology Association Congress - Abstract Number: PS1979
13/06/2025 10:00 pm European Hematology Association Congress - Abstract Number: PF920
13/06/2025 10:00 pm European Hematology Association Congress - Abstract Number: PF885
13/06/2025 10:00 pm European Hematology Association Congress - Abstract Number: PF881
09/06/2025 05:30 pm Goldman Sachs Global Healthcare Conference
05/06/2025 06:50 pm Jefferies Healthcare Conference
03/06/2025 02:30 am R&D Day
03/06/2025 12:00 am American Society of Clinical Oncology Meeting - Abstract No - 3039

Annual results

Fiscal PeriodDecember 2022 2023 2024 2025 2026 2027
Net sales
Million DKK		Released
Forecast
Spread 		14 595
14 068
3.75%		16 474
16 380
0.58%		21 526
21 279
1.16%
23 369


26 924


30 988

EBITDA
Million DKK		Released
Forecast
Spread 		6 719
6 371
5.46%		5 616
5 721
-1.83%		7 116
6 933
2.64%
8 275


9 607


12 190

EBIT
Million DKK		Released
Forecast
Spread 		6 357
6 008
5.81%		5 321
5 398
-1.42%		7 003
6 441
8.72%
7 660


9 254


11 533

Earnings before Tax (EBT)
Million DKK		Released
Forecast
Spread 		7 035
8 905
-21%		5 637
6 236
-9.6%		9 164
7 451
22.98%
8 677


10 282


12 896

Net income
Million DKK		Released
Forecast
Spread 		5 522
6 793
-18.71%		4 352
4 989
-12.77%		7 844
5 544
41.48%
6 707


7 964


10 164

EPS
DKK		Released
Forecast
Spread 		83,7
103
-18.98%		66,0
76,1
-13.23%		121
85,7
41.66%
103


120


153

Announcement Date22/02/2314/02/2412/02/25-

Quarterly results

Fiscal PeriodMarch 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4
Net sales
Million DKK		Released
Forecast
Spread 		7 052
6 896
2.26%		4 744
4 474
6.03%		4 678
4 610
1.48%		4 143
3 989
3.86%		5 402
4 959
8.94%		9 545
9 039
5.6%		5 540
5 646
-1.89%		6 441
6 391
0.79%		4 731
5 019
-5.73%
5 813


6 153


6 611


5 745


7 049


7 405


7 787

EBITDA
Million DKK		Released
Forecast
Spread 		1 978
2 145
-7.79%		1 739
1 646
5.65%		1 899
1 804
5.28%		823
880
-6.45%		1 804
1 571
14.84%		2 627
2 412
8.91%		2 129
1 847
15.25%		2 275
1 966
15.72%		1 350
986
36.95%
2 207


2 206


1 955


2 592










EBIT
Million DKK		Released
Forecast
Spread 		1 934
1 977
-2.18%		1 717
1 702
0.87%		1 670
1 772
-5.73%		801
832
-3.68%		1 640
1 599
2.57%		2 441
2 229
9.51%		2 102
1 782
17.95%		2 191
1 945
12.67%		1 244
1 069
16.32%
2 079


2 240


2 125


1 406


2 622


2 952


3 273

Earnings before Tax (EBT)
Million DKK		Released
Forecast
Spread 		2 009
1 927
4.26%		2 702
1 774
52.33%		926
1 888
-50.95%		1 716
1 064
61.28%		2 127
1 847
15.15%		3 843
3 374
13.9%		1 719
1 761
-2.38%		3 602
2 037
76.79%		1 615
1 214
32.96%
2 227


2 349


2 428


1 533


2 757


3 099


3 433

Net income
Million DKK		Released
Forecast
Spread 		1 583
1 503
5.32%		2 129
1 382
54.01%		640
1 439
-55.52%		1 325
833
59.07%		1 408
1 426
-1.28%		2 733
2 598
5.2%		1 266
1 373
-7.77%		3 845
1 606
139.45%		1 290
1 068
20.84%
1 669


1 846


1 835


1 227


2 206


2 479


2 747

EPS
DKK		Released
Forecast
Spread 		24,0
22,7
5.86%		32,3
20,8
55.21%		9,67
22,3
-56.65%		20,2
12,9
56.06%		21,7
21,8
-0.34%		41,9
39,5
5.92%		19,8
21,3
-6.93%		59,6
25,0
138.85%		20,2
16,0
26.14%
24,8


27,6


27,8


20,4


35,1


38,2


42,0

Announcement Date03/08/2307/11/2314/02/2402/05/2408/08/2408/08/2406/11/2412/02/2508/05/25-------

Upcoming sector events for Genmab A/S

23/07/2025 VIKING THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)
29/07/2025 WUXI APPTEC CO., LTD.: Q2 2025 Earnings Release
30/07/2025 CASSAVA SCIENCES, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025 XENCOR, INC.: Q2 2025 Earnings Release (Projected)
31/07/2025 DYNE THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)
31/07/2025 KURA ONCOLOGY, INC.: Q2 2025 Earnings Release (Projected)
31/07/2025 SANA BIOTECHNOLOGY, INC.: Q2 2025 Earnings Release (Projected)
31/07/2025 KEROS THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)
31/07/2025 INSMED INCORPORATED: Q2 2025 Earnings Release (Projected)
31/07/2025 SPYRE THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)
More events

Past sector events for Genmab A/S

10/07/2025 01:31 am NURIX THERAPEUTICS, INC.: Q2 2025 Earnings Release
05/07/2025 07:54 am PHARMAESSENTIA CORPORATION: June 2025 Sales and Revenue Release
03/07/2025 KALVISTA PHARMACEUTICALS, INC.: Q4 2025 Earnings Release (Projected)
13/06/2025 SANBIO COMPANY LIMITED: Q1 2025 Earnings Release
09/06/2025 12:16 pm LUMOSA THERAPEUTICS CO., LTD.: May 2025 Sales and Revenue Release
05/06/2025 01:51 pm PHARMAESSENTIA CORPORATION: May 2025 Sales and Revenue Release
05/06/2025 01:16 pm TAIMED BIOLOGICS INC.: May 2025 Sales and Revenue Release
15/05/2025 05:30 pm TAYSHA GENE THERAPIES, INC.: Q1 2025 Earnings Release
15/05/2025 LIGACHEM BIOSCIENCES INC.: Q1 2025 Earnings Release
15/05/2025 PEPTRON, INC.: Q1 2025 Earnings Release

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. GMAB Stock
  4. Calendar Genmab A/S

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States
United-States
Canada
Canada

MIDDLE EAST

Saudi Arabia
Saudi Arabia
United Arab Emirates
United Arab Emirates

EUROPE

France
France
Deutschland
Deutschland
Suisse
Suisse
Schweiz
Schweiz
Italia
Italia
Österreich
Österreich
België
België
Nederland
Nederland
España
España
Sverige
Sverige
United Kingdom
United Kingdom

APAC

Australia
Australia
India
India
Hong Kong
Hong Kong
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition